Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has shared an update.
Shanghai Pharmaceuticals Holding Co., Ltd. announced a final cash dividend of RMB 2.9 per 10 shares for the financial year ending December 31, 2024. This announcement reflects the company’s ongoing commitment to returning value to its shareholders. The dividend will be subject to withholding tax, with specific rates depending on the shareholder’s residency and applicable tax treaties with China. This move is likely to impact the company’s financial operations and shareholder relations, reinforcing its position in the market.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products and healthcare services. The company is a significant player in the Chinese market, catering to both domestic and international demands.
YTD Price Performance: -8.59%
Average Trading Volume: 33,967
Technical Sentiment Signal: Sell
Current Market Cap: $7.67B
For detailed information about 2607 stock, go to TipRanks’ Stock Analysis page.